Associated Papers
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2).
Swisher EM et al.
Nature Communications, 2021
33941784 (PubMed )
Supplement: 41467_2021_22582_MOESM1_ESM.pdf
Select a paper to view details